The Health Outcomes Management and Evaluation (HOME) Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 447 participants.

Also called NCT01228032

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 447 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01228032
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01228032. Randomized; single masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2015-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Health Outcomes Management and Evaluation (HOME) Study
Acronym
HOME
Condition
Diabetes
Condition
Hyperlipidemia
Condition
Heart Disease
Intervention (Other)
Care team
Lead sponsor
Emory University (class: other)
Collaborator
National Institute of Mental Health (NIMH) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct01228032
Content hash
3d80331011c45aa2bc2d4250fde9d7f66a77e0de08418a2bf748db61b7b5fdf8